Hereditary BC accounts for only 5–10% of all BC cases and germline mutations, with the two significant BC susceptibility genes, BRCA1 and BRCA2 is responsible for approximately 2–3% of all cases (Kwong et al., 2016). This evidence concerns the gene BRCA2 and breast cancer.